We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+5.87%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$94.6B
AUM Growth
+$6.28B
Cap. Flow
+$2.19B
Cap. Flow %
2.31%
Top 10 Hldgs %
26.12%
Holding
8,150
New
480
Increased
3,032
Reduced
3,756
Closed
467

Sector Composition

Rank Sector Weight
1 Healthcare 4.89%
2 Energy 4.68%
3 Technology 4.17%
4 Communication Services 3.74%
5 Financials 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDSO
5601
DELISTED
Medidata Solutions, Inc.
MDSO
$69K ﹤0.01%
1,652
-9,311
-85% -$387K
IGLD
5602
DELISTED
Internet Gold-Golden Lines Ltd
IGLD
$69K ﹤0.01%
69
-51
-43% -$51.8K
HF
5603
DELISTED
HFF Inc.
HF
$69K ﹤0.01%
1,875
-1,676
-47% -$55.8K
CFFN icon
5604
Capitol Federal Financial
CFFN
$1.09B
$68K ﹤0.01%
5,732
-1,114
-16% -$13.5K
HALO icon
5605
CALL
Halozyme
HALO
$9.79B
$68K ﹤0.01%
7,500
PGNX
5606
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$68K ﹤0.01%
17,065
-28,849
-63% -$110K
IO
5607
PUT
DELISTED
ION Geophysical Corporation
IO
$68K ﹤0.01%
1,133
+20
+2% +$1.26K
AKBA icon
5608
Akebia Therapeutics
AKBA
$354M
$67K ﹤0.01%
+2,481
New +$59.7K
CVSA
5609
CALL
Covista Inc
CVSA
$4.25B
$67K ﹤0.01%
1,600
-6,600
-80% -$281K
CORN icon
5610
CALL
Teucrium Corn Fund
CORN
$176M
$67K ﹤0.01%
2,300
+1,600
+229% +$52.8K
GORO icon
5611
Goldgroup Mining Inc.
GORO
$157M
$67K ﹤0.01%
13,544
+12,183
+895% +$55.6K
WAL icon
5612
Western Alliance Bancorporation
WAL
$8.79B
$67K ﹤0.01%
2,919
-2,473
-46% -$58.1K
RVNC
5613
DELISTED
Revance Therapeutics, Inc.
RVNC
$67K ﹤0.01%
1,979
+1,791
+953% +$56.1K
EGIO
5614
DELISTED
Edgio, Inc. Common Stock
EGIO
$67K ﹤0.01%
558
+390
+232% +$37K
SCMP
5615
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$67K ﹤0.01%
11,077
+697
+7% +$4.93K
WSTL
5616
DELISTED
Westell Technologies Inc
WSTL
$67K ﹤0.01%
8,400
-4,804
-36% -$55.9K
NILE
5617
CALL
DELISTED
Blue Nile, Inc.
NILE
$67K ﹤0.01%
2,400
-2,500
-51% -$78.7K
SGI
5618
CALL
DELISTED
Silicon Graphics Intl.
SGI
$67K ﹤0.01%
7,400
-500
-6% -$5.05K
WHZ
5619
DELISTED
WHITING USA TR II TR UNIT (DE)
WHZ
$67K ﹤0.01%
5,600
+5,461
+3,929% +$70.6K
FSS icon
5620
Federal Signal
FSS
$7.63B
$66K ﹤0.01%
4,640
-106,976
-96% -$1.57M
CBIO
5621
Crescent Biopharma
CBIO
$537M
$66K ﹤0.01%
83
+81
+4,050% +$80.6K
IMOS
5622
ChipMOS TECHNOLOGIES
IMOS
$1.65B
$66K ﹤0.01%
2,512
-11,301
-82% -$284K
MTDR icon
5623
Matador Resources
MTDR
$6.2B
$66K ﹤0.01%
2,268
-3,086
-58% -$81.5K
OMEX icon
5624
Odyssey Marine Exploration
OMEX
$34.9M
$66K ﹤0.01%
5,501
+3,491
+174% +$75K
PNFP icon
5625
Pinnacle Financial Partners Inc
PNFP
$15.9B
$66K ﹤0.01%
1,703
+273
+19% +$9.79K

Similar funds

Barclays's Q2 2014 Portfolio in Review

As of Q2 2014, Barclays held 8,150 positions worth $94.6B, up 7.1% from $88.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Barclays's Q2 2014 filing shows 480 new, 3,032 increased, 3,756 reduced and 467 closed positions. Its largest new stake was Blackstone Mortgage Trust: 1,000,000 shares worth $29M. The largest sale was Calpine Corporation, an estimated $298M.

By sector, the portfolio is most concentrated in Healthcare at 4.9% of assets, down from 5.8% a quarter earlier, followed by Energy and Technology.

  • Barclays's largest Q2 2014 buy was Blackstone Mortgage Trust: 1,000,000 shares worth $29M.
  • Barclays added most to Phillips 66 in Q2 2014, an estimated $637M increase.
  • Barclays's biggest Q2 2014 reduction was Calpine Corporation, cutting an estimated $298M.
  • Barclays fully exited BRE PROPERTIES INC CL A in Q2 2014, selling an estimated $91.7M.
  • Barclays's ten largest holdings make up 26% of its $94.6B portfolio in Q2 2014.
  • Barclays opened 480 new positions and closed 467 in Q2 2014.
  • Barclays's portfolio value rose 7.1% quarter-over-quarter to $94.6B.

Based on Barclays's 13F filing for Q2 2014, filed 14 Aug 2014.